Mary Lee Vance Selected Research

Mary Lee Vance Research Topics

Disease

26	Neoplasms (Cancer) 12/2023 - 01/2002
24	Pituitary Neoplasms (Pituitary Adenoma) 12/2023 - 01/2002
21	Pituitary ACTH Hypersecretion 11/2023 - 11/2002
15	Acromegaly 11/2018 - 01/2002
12	Adenoma (Adenomas) 03/2019 - 01/2002
8	Hypopituitarism (Sheehan's Syndrome) 12/2023 - 09/2005
4	ACTH-Secreting Pituitary Adenoma 11/2023 - 06/2007
4	Prolactinoma (Prolactinomas) 12/2015 - 01/2003
4	Pituitary Diseases (Disease, Anterior Pituitary) 03/2014 - 08/2003
3	Hyperpigmentation 01/2021 - 06/2007
3	Cushing Syndrome 11/2017 - 04/2004
2	Residual Neoplasm 12/2023 - 11/2003
2	Combined Pituitary Hormone Deficiency 04/2014 - 10/2008
2	Diabetes Insipidus 08/2011 - 11/2005
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023
1	Inappropriate ADH Syndrome (SIADH) 02/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 11/2017
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 04/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2009
1	Insulin Resistance 11/2008
1	Frailty 11/2008
1	Sarcopenia 11/2008
1	Body Weight (Weight, Body) 11/2008
1	Hypothyroidism 06/2007
1	Vascular System Injuries 11/2005
1	Growth Hormone-Secreting Pituitary Adenoma 07/2005
1	Gallstones (Gallstone) 05/2005
1	Hyperprolactinemia 01/2005
1	Weight Loss (Weight Reduction) 01/2005
1	Hypophysitis 08/2004
1	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2003

Drug/Important Bio-Agent (IBA)

17	Hormones (Hormone)IBA 12/2023 - 01/2003
17	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023 - 11/2002
10	Growth Hormone (Somatotropin)IBA 01/2018 - 01/2002
9	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 11/2002
7	Insulin-Like Growth Factor I (IGF-1)IBA 06/2017 - 01/2002
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2015 - 01/2002
6	Dopamine Agonists (Dopamine Agonist)IBA 12/2015 - 01/2003
5	pegvisomant FDA LinkGeneric 03/2008 - 01/2002
4	Octreotide (Sandostatin)FDA LinkGeneric 12/2017 - 05/2005
4	Insulin (Novolin)FDA Link 06/2017 - 04/2002
3	ProlactinIBA 03/2008 - 01/2003
2	Dihydrotachysterol (AT 10)IBA 12/2023 - 11/2017
2	lanreotide (Somatuline)FDA Link 07/2005 - 01/2002
1	SodiumIBA 02/2022
1	Vasopressins (Vasopressin)IBA 02/2022
1	Keratins (Keratin)IBA 03/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2019
1	Hematoxylin (Haematoxylon)IBA 03/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2014
1	MicroRNAs (MicroRNA)IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 12/2012
1	Messenger RNA (mRNA)IBA 12/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2012
1	GonadotropinsIBA 08/2011
1	Insulin-Like PeptidesIBA 08/2011
1	Thyroid HormonesIBA 08/2011
1	Temozolomide (Temodar)FDA LinkGeneric 11/2010
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 11/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2010
1	EpitopesIBA 01/2010
1	LipidsIBA 11/2008
1	Blood Glucose (Blood Sugar)IBA 11/2008
1	ibutamoren mesylateIBA 11/2008
1	Cabergoline FDA LinkGeneric 03/2008
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2006
1	GlucocorticoidsIBA 11/2005
1	Glucose (Dextrose)FDA LinkGeneric 10/2005
1	LigandsIBA 07/2005
1	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2005
1	salicylhydroxamic acid (SHAM)IBA 01/2005
1	Coloring Agents (Dyes)IBA 11/2003
1	Testosterone (Sustanon)FDA Link 08/2003

Therapy/Procedure

19	Therapeutics 12/2017 - 01/2002
9	Radiotherapy 01/2018 - 06/2003
7	Adrenalectomy 01/2021 - 06/2007
3	Aftercare (After-Treatment) 03/2019 - 09/2003
2	Craniotomy 02/2011 - 01/2005
2	Hypophysectomy 10/2008 - 09/2005
1	Patient Readmission 02/2022
1	Pituitary Irradiation 11/2017
1	Endoscopes 09/2011
1	Duration of Therapy 11/2010
1	Glycemic Control 10/2005